Patrick Crutcher

39 year

Consumer Services

Health Technology

Profile

Patrick J.
Crutcher is currently the President & Chief Executive Officer at AlmataBio, Inc. Previously, he served as the Chairman & President at Ichorion Therapeutics, Inc. from 2017 to 2018.
He also worked as the Chief Strategy Officer at Avalo Therapeutics, Inc. in 2019.
Mr. Crutcher holds a graduate degree from the University of California, Los Angeles and an undergraduate degree from the University of Illinois.

Patrick Crutcher active positions

Companies	Position	Start

All active positions of Patrick Crutcher

Former positions of Patrick Crutcher

Companies	Position	End
AVALO THERAPEUTICS, INC.	Corporate Officer/Principal	2019-10-31
Ichorion Therapeutics, Inc. Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY.	Chief Executive Officer	2018-08-31

See the detail of Patrick Crutcher's experience

Training of Patrick Crutcher

University of California, Los Angeles	Graduate Degree
University of Illinois	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Crutcher's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AVALO THERAPEUTICS, INC.	Health Technology

Private companies	1
Ichorion Therapeutics, Inc. Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY.	Health Technology